Lamotrigine Tablet, Extended Release
Product Images NDC 70518-4121

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-4121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Lamotrigine 50 mg extended-release oral tablets in a package labeled to contain 30 tablets. The label shows the brand RemedyRepack and notes the product is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturing is noted as Dr. Reddy's, Shreveport, LA. The label includes an NDC barcode, QR code, and storage instructions.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier responder rate curve comparing Lamotrigine extended release tablets (solid line) and placebo (dashed line). The vertical axis represents responder rate from worsening (-100%) to improvement (100%). The horizontal axis shows percent of patients from 100% to 0%. The chart illustrates patient response over time for both groups.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing responder rates (equal or greater improvement versus worsening) between lamotrigine extended-release tablets and placebo across the percent of patients. The graph features two lines: a solid line for lamotrigine extended-release tablets (N=116) and a dashed line for placebo (N=120), showing higher responder rates for lamotrigine.*

FDA Label Image

Pictures (Pictures)

Lamotrigine extended release oral tablets by Remedyrepack Inc., shown in multiple strengths and colors. The image displays six tablet variations: 25 mg yellow round tablets with 'R717' imprint; 50 mg light green round tablets with 'R718' imprint; 100 mg orange round tablets with 'R719' imprint; 200 mg blue round tablets with 'R720' imprint; 250 mg purple oval tablets with 'R419' imprint; and 300 mg grey modified capsule-shaped tablets with 'R428' imprint, each imprinted on one side and plain on the other.*

FDA Label Image

Structure (Structure)

Chemical structure of lamotrigine, illustrating its molecular framework including chlorine atoms, nitrogen atoms, and amino groups consistent with the active ingredient lamotrigine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.